• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP10 通过去泛素化和稳定 YAP/TAZ 促进肝癌增殖。

USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.

机构信息

Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

Center for Drug Safety Evaluation and Research of Zhejiang University, Hangzhou, China.

出版信息

Cancer Res. 2020 Jun 1;80(11):2204-2216. doi: 10.1158/0008-5472.CAN-19-2388. Epub 2020 Mar 26.

DOI:10.1158/0008-5472.CAN-19-2388
PMID:32217697
Abstract

Yes-associated protein (YAP) and its paralog, transcriptional coactivator with PDZ-binding motif (TAZ), play pivotal roles in promoting the progression of hepatocellular carcinoma. However, the regulatory mechanism underpinning aberrant activation of YAP/TAZ in hepatocellular carcinoma remains unclear. In this study, we globally profiled the contribution of deubiquitinating enzymes (DUB) to both transcriptional activity and protein abundance of YAP/TAZ in hepatocellular carcinoma models and identified ubiquitin-specific peptidase 10 (USP10) as a potent YAP/TAZ-activating DUB. Mechanistically, USP10 directly interacted with and stabilized YAP/TAZ by reverting their proteolytic ubiquitination. Depletion of USP10 enhanced polyubiquitination of YAP/TAZ, promoted their proteasomal degradation, and ultimately arrested the proliferation of hepatocellular carcinoma and . Expression levels of USP10 positively correlated with the abundance of YAP/TAZ in hepatocellular carcinoma patient samples as well as in N-nitrosodiethylamine (DEN)-induced liver cancer mice models. Collectively, this study establishes the causal link between USP10 and hyperactivated YAP/TAZ in hepatocellular carcinoma cells and provides a rationale for potential therapeutic interventions in the treatment of patients with hepatocellular carcinoma harboring a high level of YAP/TAZ. SIGNIFICANCE: These findings identify USP10 as a DUB of YAP/TAZ and its role in hepatocellular carcinoma progression, which may serve as a potential therapeutic target for hepatocellular carcinoma treatment.

摘要

Yes 相关蛋白 (YAP) 和其同源蛋白,PDZ 结合基序的转录共激活因子 (TAZ),在促进肝细胞癌的进展中起着关键作用。然而,导致 YAP/TAZ 在肝细胞癌中异常激活的调控机制尚不清楚。在这项研究中,我们全面分析了去泛素化酶 (DUB) 对肝细胞癌模型中 YAP/TAZ 的转录活性和蛋白丰度的贡献,并鉴定出泛素特异性肽酶 10 (USP10) 是一种有效的 YAP/TAZ 激活 DUB。从机制上讲,USP10 通过逆转其蛋白水解泛素化作用直接与 YAP/TAZ 相互作用并稳定其蛋白。USP10 的耗竭增强了 YAP/TAZ 的多泛素化,促进了它们的蛋白酶体降解,并最终阻止了肝细胞癌的增殖。和。USP10 的表达水平与肝细胞癌患者样本以及 N-亚硝二乙胺 (DEN) 诱导的肝癌小鼠模型中 YAP/TAZ 的丰度呈正相关。总之,这项研究确立了 USP10 与肝细胞癌细胞中高活性 YAP/TAZ 之间的因果关系,并为针对携带高 YAP/TAZ 水平的肝细胞癌患者的潜在治疗干预提供了依据。意义:这些发现确定了 USP10 是 YAP/TAZ 的 DUB 及其在肝细胞癌进展中的作用,这可能成为肝细胞癌治疗的潜在治疗靶点。

相似文献

1
USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.USP10 通过去泛素化和稳定 YAP/TAZ 促进肝癌增殖。
Cancer Res. 2020 Jun 1;80(11):2204-2216. doi: 10.1158/0008-5472.CAN-19-2388. Epub 2020 Mar 26.
2
Simultaneous knockdown of YAP and TAZ increases apoptosis of hepatocellular carcinoma cells under hypoxic condition.在缺氧条件下,同时敲低 YAP 和 TAZ 可增加肝癌细胞的凋亡。
Biochem Biophys Res Commun. 2019 Jul 23;515(2):275-281. doi: 10.1016/j.bbrc.2019.05.143. Epub 2019 May 28.
3
Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.去泛素化酶 USP10 通过去泛素化和稳定 Smad4 蛋白促进肝癌转移。
Mol Oncol. 2020 Jan;14(1):197-210. doi: 10.1002/1878-0261.12596. Epub 2019 Nov 27.
4
An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.TAZ 和 YAP 在肝癌中的表达失衡赋予了肝癌干细胞样行为,促进了疾病进展。
Cancer Res. 2015 Nov 15;75(22):4985-97. doi: 10.1158/0008-5472.CAN-15-0291. Epub 2015 Sep 29.
5
The calcimimetic agent cinacalcet inhibits hepatocellular carcinoma via YAP/TAZ suppression.钙敏感受体激动剂西那卡塞通过抑制 YAP/TAZ 抑制肝癌。
Pharmazie. 2021 Oct 1;76(10):511-514. doi: 10.1691/ph.2021.1646.
6
SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ.琥珀酸脱氢酶亚单位 B(SDHA/B)减少通过促进连接酶 1(cullin1)去泛素化和稳定 YAP/TAZ 促进肝细胞癌。
Hepatology. 2023 Jul 1;78(1):103-119. doi: 10.1002/hep.32621. Epub 2022 Jul 6.
7
Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression.通过调节 YAP 表达发现具有抗肝癌活性的强效小分子泛素特异性蛋白酶 10 抑制剂。
Eur J Med Chem. 2024 Jun 5;272:116468. doi: 10.1016/j.ejmech.2024.116468. Epub 2024 May 5.
8
A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.USP14-TAZ 自扩增环驱动胰腺导管腺癌的进展和肝转移。
Cell Death Differ. 2023 Jan;30(1):1-15. doi: 10.1038/s41418-022-01040-w. Epub 2022 Jul 29.
9
Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.Nogo-B 通过增强 Yap/Taz 介导的肿瘤相关巨噬细胞 M2 极化促进 HCC 进展。
Exp Cell Res. 2020 Jun 1;391(1):111979. doi: 10.1016/j.yexcr.2020.111979. Epub 2020 Apr 1.
10
TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.TAZ 靶基因 ITGAV 调控肝癌细胞的侵袭,并正向反馈于 YAP 和 TAZ。
Cancer Lett. 2020 Mar 31;473:164-175. doi: 10.1016/j.canlet.2019.12.044. Epub 2020 Jan 3.

引用本文的文献

1
USP10-mediated Ku70/80 stabilization inhibits PANoptosis and promotes chemoresistance in colorectal cancer.USP10介导的Ku70/80稳定化抑制全程序性细胞死亡并促进结直肠癌的化疗耐药性。
Oncogene. 2025 Sep 18. doi: 10.1038/s41388-025-03570-2.
2
Targeting phase separation: a promising treatment option for hepatocellular carcinoma.靶向相分离:肝细胞癌一种有前景的治疗选择。
Cell Commun Signal. 2025 Sep 1;23(1):387. doi: 10.1186/s12964-025-02406-6.
3
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities.
YAP/TAZ的翻译后修饰:分子机制与治疗机遇
Cell Mol Biol Lett. 2025 Jul 17;30(1):83. doi: 10.1186/s11658-025-00760-4.
4
USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC.USP10通过稳定胰腺导管腺癌(PDAC)中的PLK1来促进其进展并减弱吉西他滨化疗敏感性。
Cell Death Dis. 2025 Jun 14;16(1):449. doi: 10.1038/s41419-025-07757-z.
5
USP39 promote post-translational modifiers to stimulate the progress of cancer.USP39促进翻译后修饰以刺激癌症进展。
Discov Oncol. 2025 May 13;16(1):749. doi: 10.1007/s12672-025-02573-5.
6
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1.USP24通过去泛素化和稳定YAP1促进肝细胞癌进展。
Cancer Cell Int. 2025 Apr 26;25(1):164. doi: 10.1186/s12935-025-03796-w.
7
USP10 stabilizes BAZ1A to drive tumor stemness via an epigenetic mechanism in head and neck squamous cell carcinoma.USP10通过表观遗传机制稳定BAZ1A,以驱动头颈部鳞状细胞癌中的肿瘤干性。
Cell Death Dis. 2025 Apr 10;16(1):270. doi: 10.1038/s41419-025-07462-x.
8
VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination-Dependent Degradation.VCP通过介导BAP1泛素化依赖性降解促进胆管癌发展。
Cancer Sci. 2025 Jun;116(6):1579-1591. doi: 10.1111/cas.70061. Epub 2025 Mar 23.
9
USP10/XAB2/ANXA2 axis promotes DNA damage repair to enhance chemoresistance to oxaliplatin in colorectal cancer.USP10/XAB2/ANXA2轴促进DNA损伤修复,增强结直肠癌对奥沙利铂的化疗耐药性。
J Exp Clin Cancer Res. 2025 Mar 11;44(1):94. doi: 10.1186/s13046-025-03357-z.
10
SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10.SPICE1通过增强由USP10介导的FASN去泛素化来促进骨肉瘤生长。
J Transl Med. 2025 Feb 21;23(1):220. doi: 10.1186/s12967-025-06248-1.